Standout Papers
- Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial (2011)
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial (2014)
- PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer (2016)
- Stereotactic body radiotherapy for oligometastases (2012)
Immediate Impact
3 by Nobel laureates 8 from Science/Nature 115 standout
Citing Papers
Radiotherapy toxicities: mechanisms, management, and future directions
2025 Standout
Thyroid Cancer
2024 Standout
Works of Christopher M. Nutting being referenced
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
2021
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
2014 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christopher M. Nutting | 3350 | 3607 | 2446 | 2515 | 190 | 9.7k | |
| Kate Newbold | 1881 | 2043 | 2280 | 2120 | 141 | 8.9k | |
| William H. Morrison | 9471 | 5404 | 7066 | 5305 | 258 | 14.9k | |
| Eric J. Sherman | 2775 | 2310 | 2593 | 3194 | 261 | 8.3k | |
| Merrill S. Kies | 5611 | 5225 | 5065 | 7226 | 177 | 14.3k | |
| Francis P. Worden | 3447 | 2224 | 3020 | 3354 | 250 | 8.8k | |
| Richard J. Wong | 3231 | 1994 | 3648 | 3539 | 283 | 9.9k | |
| Erich M. Sturgis | 4744 | 2422 | 3111 | 3887 | 302 | 10.7k | |
| Anthony J. Cmelak | 5814 | 2686 | 3734 | 3309 | 144 | 9.1k | |
| Primož Strojan | 3005 | 1796 | 3016 | 2444 | 242 | 7.6k | |
| Sandra Nuyts | 2684 | 1740 | 1646 | 1177 | 213 | 6.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...